Association between lymphocyte-to-monocyte ratio and stroke-associated pneumonia: a retrospective cohort study

Xiaoqiang Li1, Xiangmao Zhou2, Hui Wang1

  • 1Department of Neurology, Xiaolan People's Hospital of Zhongshan (The Fifth People's Hospital of Zhongshan), Zhongshan, Guangdong, China.

Peerj
|December 16, 2024
PubMed
Abstract

Insights

The lymphocyte-to-monocyte ratio (LMR) can predict stroke-associated pneumonia (SAP) in acute ischemic stroke (AIS) patients. A lower LMR indicates a higher risk of developing SAP after stroke.

Area of Science:

  • Neurology
  • Immunology
  • Inflammation

Background:

  • Stroke-associated pneumonia (SAP) is a frequent and serious complication following acute ischemic stroke (AIS).
  • SAP significantly increases mortality rates and prolongs hospital stays in AIS patients.
  • The lymphocyte-to-monocyte ratio (LMR) is an emerging inflammatory marker, but its role in SAP following AIS is not well-defined.

Purpose of the Study:

  • To investigate the association between the lymphocyte-to-monocyte ratio (LMR) and the incidence of stroke-associated pneumonia (SAP) in patients with acute ischemic stroke (AIS).
  • To determine if LMR can serve as an independent predictor for SAP in AIS patients.

Main Methods:

  • A retrospective cohort study included 1,063 patients with AIS.
  • Patients were categorized into SAP (n=99) and non-SAP (n=964) groups.
  • Lymphocyte-to-monocyte ratio (LMR) was measured within 24 hours of admission; logistic regression analyses were used to assess the relationship with SAP.

Main Results:

  • The incidence of SAP was 9.31%.
  • Patients with SAP had significantly lower LMR compared to the non-SAP group (2.46 ± 1.44 vs. 3.86 ± 1.48, P < 0.001).
  • A lower LMR (<4) was independently associated with a reduced risk of SAP (OR = 0.37, 95% CI [0.27-0.53]).

Conclusions:

  • The lymphocyte-to-monocyte ratio (LMR) is an independent predictor of stroke-associated pneumonia (SAP) in patients with acute ischemic stroke (AIS).
  • An LMR below 4 is particularly indicative of increased SAP risk.
  • LMR shows potential as a biomarker for early risk stratification of SAP in AIS patients.